CNY 16.65
(0.12%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 8.11 Billion | 24.37 Billion | 12.32 Billion | 11.01 Billion | 8.15 Billion | 1.17 Billion |
Net Income | 10.75 Billion | 14.81 Billion | 9.08 Billion | 8.55 Billion | 5.27 Billion | 2.55 Billion |
Depreciation & Amortization | 4.97 Billion | 3.68 Billion | 3.45 Billion | 2.22 Billion | 1.48 Billion | 1.2 Billion |
Deferred income taxes | -240.27 Million | - | - | - | - | - |
Stock-based compensation | 693.96 Million | - | - | - | - | - |
Change in working capital | -12.11 Billion | -9.51 Billion | -4.76 Billion | -8.39 Billion | -4.38 Billion | -6.15 Billion |
Other non-cash items | 3.8 Billion | 15.38 Billion | 4.53 Billion | 8.63 Billion | 5.77 Billion | 3.56 Billion |
Investing Cash Flow | -5.63 Billion | -5.05 Billion | -7.14 Billion | -5.17 Billion | -2.75 Billion | -3.16 Billion |
Investments in PPE | -9.25 Billion | -5 Billion | -4.9 Billion | -4.82 Billion | -2.68 Billion | -3.82 Billion |
Acquisitions | 72.9 Million | - | -7195.00 | -873.42 Million | - | - |
Investment purchases | -9.38 Billion | - | - | - | - | - |
Sales/Maturities of investments | 12.88 Billion | - | - | - | - | - |
Other Investing Activities | 3.61 Billion | -43.63 Million | -2.23 Billion | 529.21 Million | -63.25 Million | 655.08 Million |
Financing Cash Flow | 314.73 Million | 4.29 Billion | -2.08 Billion | 2.8 Billion | 4.56 Billion | 267.45 Million |
Debt repayment | -3.25 Billion | -4.3 Billion | -5 Billion | -4.42 Billion | -2.9 Billion | -1.8 Billion |
Dividends payments | -3.03 Billion | -1.55 Billion | -1.15 Billion | -1.78 Billion | -720.66 Million | -669.46 Million |
Common Stock Repurchased | -97.04 Million | -170.49 Thousand | -120.66 Thousand | -667.77 Thousand | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 551.27 Million | 176.03 Million | -533.84 Million | -136.14 Million | 8.42 Billion | 342.95 Million |
Accounts receivables | -5.42 Billion | -3.49 Billion | -2.24 Billion | -4.64 Billion | -852.52 Million | -2.95 Billion |
Accounts payables | 800.39 Million | - | - | - | - | - |
Inventory | -7.38 Billion | -6.29 Billion | -2.71 Billion | -4.57 Billion | -2.43 Billion | -1.93 Billion |
Other working capital | 693.96 Million | 278.54 Million | 204.49 Million | 825.41 Million | -1.09 Billion | -1.27 Billion |
Cash at beginning of period | 51.1 Billion | 26.48 Billion | 23.9 Billion | 15.56 Billion | 5.66 Billion | 7.35 Billion |
Cash at end of period | 54.42 Billion | 51.1 Billion | 26.48 Billion | 23.9 Billion | 15.56 Billion | 5.66 Billion |
Capital Expenditure | -9.25 Billion | -5 Billion | -4.9 Billion | -4.82 Billion | -2.68 Billion | -3.82 Billion |
Effect of forex changes on cash | 523.64 Million | 1 Billion | -515.53 Million | -308.77 Million | -70.19 Million | 37.7 Million |
Net cash flow / Change in cash | 3.31 Billion | 24.61 Billion | 2.57 Billion | 8.34 Billion | 9.89 Billion | -1.69 Billion |
Free Cash Flow | -1.13 Billion | 19.36 Billion | 7.41 Billion | 6.18 Billion | 5.46 Billion | -2.65 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.26 Billion | -2.89 Billion | -2.35 Billion | -942.29 Million | 10.75 Billion | 2.51 Billion |
Depreciation & Amortization | - | 3.37 Billion | - | 4.97 Billion | 4.97 Billion | -2.77 Billion |
Deferred income taxes | - | - | - | - | -240.27 Million | - |
Stock-based compensation | - | 13.55 Million | - | 693.96 Million | 693.96 Million | -1.22 Million |
Change in working capital | - | -1.45 Billion | - | -12.11 Billion | -12.01 Billion | 8.76 Billion |
Other non-cash items | 267.89 Million | -570.55 Million | -2.53 Billion | 6.11 Billion | 31.43 Billion | -4.31 Billion |
Investing Cash Flow | -425.9 Million | -2.88 Billion | -899.16 Million | -1.54 Billion | -10.47 Billion | -2.68 Billion |
Investments in PPE | -1.42 Billion | -2.6 Billion | -807.74 Million | -1.54 Billion | -9.25 Billion | -2.12 Billion |
Acquisitions | 32.59 Million | 670.1 Million | - | - | 104.57 Million | - |
Investment purchases | -46.07 Billion | -27.48 Billion | - | - | -9.38 Billion | - |
Sales/Maturities of investments | 47.03 Billion | 27.15 Billion | - | - | 8.05 Billion | - |
Other Investing Activities | 5.34 Million | -276.49 Million | -91.42 Million | -484.35 Thousand | 1.91 Million | -557.08 Million |
Financing Cash Flow | -828.35 Million | 2.07 Billion | 5.74 Billion | 2.98 Billion | 327.74 Million | -85.45 Million |
Debt repayment | -768.01 Million | -1.29 Billion | -5.78 Billion | -3 Billion | -3.25 Billion | -514.5 Million |
Dividends payments | -1.35 Billion | -77.78 Million | -54.36 Million | -56.02 Million | -3.03 Billion | -21.3 Million |
Common Stock Repurchased | - | -96.66 Million | - | -97.04 Million | -97.04 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -241.72 Million | 1.03 Billion | 12.18 Million | 3.13 Billion | 433.2 Million | -64.14 Million |
Accounts receivables | - | 278.77 Million | - | -5.42 Billion | -5.42 Billion | 4.35 Billion |
Accounts payables | - | - | - | - | 800.39 Million | - |
Inventory | - | -1.74 Billion | - | -7.38 Billion | -7.38 Billion | 4.69 Billion |
Other working capital | - | 13.55 Million | - | 693.96 Million | 693.96 Million | -276.97 Million |
Cash at beginning of period | 52.14 Billion | 54.38 Billion | 54.42 Billion | 54.08 Billion | 54.37 Billion | 52.79 Billion |
Cash at end of period | 49.05 Billion | 52.14 Billion | 54.38 Billion | 54.42 Billion | 57 Billion | 54.08 Billion |
Capital Expenditure | -1.42 Billion | -2.6 Billion | -807.74 Million | -1.54 Billion | -9.25 Billion | -2.12 Billion |
Effect of forex changes on cash | 120.74 Million | 89.22 Million | 8.75 Million | 159.15 Million | 523.64 Million | -122.98 Million |
Net cash flow / Change in cash | -3.08 Billion | -2.24 Billion | -34.04 Million | 334.94 Million | 2.62 Billion | 1.29 Billion |
Free Cash Flow | -2.41 Billion | -4.12 Billion | -5.69 Billion | -2.8 Billion | 3.68 Billion | 2.05 Billion |
MSEXP
ARYACAPM
ROSELABS
ADN
HOVS
UNICHEMLAB